Cargando…

Repurposing Antiviral Drugs for Orthogonal RNA‐Catalyzed Labeling of RNA

In vitro selected ribozymes are promising tools for site‐specific labeling of RNA. Previously known nucleic acid catalysts attached fluorescently labeled adenosine or guanosine derivatives through 2′,5′‐branched phosphodiester bonds to the RNA of interest. Herein, we report new ribozymes that use or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghaem Maghami, Mohammad, Dey, Surjendu, Lenz, Ann‐Kathrin, Höbartner, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318677/ https://www.ncbi.nlm.nih.gov/pubmed/32162405 http://dx.doi.org/10.1002/anie.202001300

Ejemplares similares

Site-specific RNA methylation by a methyltransferase ribozyme
por: Scheitl, Carolin P. M., et al.
Publicado: (2020)

Structure–fluorescence activation relationships of a large Stokes shift fluorogenic RNA aptamer
por: Steinmetzger, Christian, et al.
Publicado: (2019)

Measurement of Angstrom to Nanometer Molecular Distances with (19)F Nuclear Spins by EPR/ENDOR Spectroscopy
por: Meyer, Andreas, et al.
Publicado: (2019)

RNA‐Cleaving Deoxyribozymes Differentiate Methylated Cytidine Isomers in RNA
por: Liaqat, Anam, et al.
Publicado: (2021)

A SAM analogue-utilizing ribozyme for site-specific RNA alkylation in living cells
por: Okuda, Takumi, et al.
Publicado: (2023)

RNA-Cleaving DNA Enzymes and Their Potential Therapeutic Applications as Antibacterial and Antiviral Agents
por: Pradeepkumar, P. I., et al.
Publicado: (2012)

Supramolecular Fluorescence Resonance Energy Transfer in Nucleobase‐Modified Fluorogenic RNA Aptamers
por: Steinmetzger, Christian, et al.
Publicado: (2020)

Mg(2+)-dependent conformational changes and product release during DNA-catalyzed RNA ligation monitored by Bimane fluorescence
por: Turriani, Elisa, et al.
Publicado: (2015)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
por: Gangadharan, Sivakumar, et al.
Publicado: (2022)

Large Stokes shift fluorescence activation in an RNA aptamer by intermolecular proton transfer to guanine
por: Mieczkowski, Mateusz, et al.
Publicado: (2021)

Ruthenium‐Catalyzed Azide–Thioalkyne Cycloadditions in Aqueous Media: A Mild, Orthogonal, and Biocompatible Chemical Ligation
por: Destito, Paolo, et al.
Publicado: (2017)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

NSUN6 is a human RNA methyltransferase that catalyzes formation of m(5)C72 in specific tRNAs
por: Haag, Sara, et al.
Publicado: (2015)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates
por: Levengood, Matthew R., et al.
Publicado: (2016)

High-resolution measurement of long-range distances in RNA: pulse EPR spectroscopy with TEMPO-labeled nucleotides
por: Halbmair, Karin, et al.
Publicado: (2016)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Trypsiligase‐Catalyzed Labeling of Proteins on Living Cells
por: Liebscher, Sandra, et al.
Publicado: (2021)

A novel strategy for orthogonal genetic regulation on different RNA targeted loci simultaneously
por: Guo, Yongjian, et al.
Publicado: (2022)

L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies
por: Sendama, Wezi
Publicado: (2020)

Advancements in Drug Repurposing: Examples in Psychiatric Medications
por: Okuyama, Ryo
Publicado: (2023)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022)

Prebiotically Plausible RNA Activation Compatible with Ribozyme‐Catalyzed Ligation
por: Song, Emilie Yeonwha, et al.
Publicado: (2020)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

A Multi-Label Learning Framework for Drug Repurposing
por: Mei, Suyu, et al.
Publicado: (2019)

New Deoxyribozymes for the Native Ligation of RNA
por: Scheitl, Carolin P. M., et al.
Publicado: (2020)

Orthogonality of Pyrrolysine tRNA in the Xenopus oocyte
por: Infield, Daniel T., et al.
Publicado: (2018)

High Efficiency Drug Repurposing Design for New Antifungal Agents
por: Kim, Jong H., et al.
Publicado: (2019)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
por: Sezer, Abas, et al.
Publicado: (2022)

Immigrants Serving in Local Government: A Systematic Review and Meta-Analysis of Factors Affecting Candidacy and Election
por: Ghaem-Maghami, Shervin, et al.
Publicado: (2021)

Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight
por: Begum, Feroza, et al.
Publicado: (2021)

Multistimuli‐Responsive [3]Dioxaphosphaferrocenophanes with Orthogonal Switches
por: Birenheide, Bernhard S., et al.
Publicado: (2021)

The Rabies Virus L Protein Catalyzes mRNA Capping with GDP Polyribonucleotidyltransferase Activity
por: Ogino, Minako, et al.
Publicado: (2016)

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Publicado: (2020)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b91jsse60gl79mn23s5a41kv3g